Stories tagged 'south africa'

Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’

Dec. 1, 2016
| By Mary Engel / Fred Hutch News Service

World’s AIDS Day 2016 brings especially hopeful news: A large-scale clinical trial has opened in South Africa to test an experimental HIV vaccine regimen that could lead to the first licensed vaccine against the virus that causes AIDS.

Community trust is key as researchers start a new trial across 15 sites in South Africa

Nov. 29, 2016
| By Mary Engel / Fred Hutch News Service

Dr. Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and a member of the Fred Hutch-based HIV Vaccine Trials Network, works closely with the communities most affected by HIV to end the epidemic. She is co-chairing a just-launched clinical trial in South Africa that could lead to the first licensed HIV vaccine.

AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands

Oct. 21, 2016
| By Mary Engel / Fred Hutch News Service

The AMP study in sub-Saharan Africa will test whether an antibody infusion protects women against HIV. If it does, the finding will have particular significance for an epidemic that hits women on that continent especially hard and for which they have few prevention options.

Community plays key role in testing a modified version of ‘Thai vaccine’ regimen

Feb. 18, 2015
| By Mary Engel / Fred Hutch News Service

As studies that could lead to the first licensed HIV vaccine get underway, a core partner in the effort is what is generally called “the community” – the thousands of volunteers who will take part in the trials and those who serve on volunteer community advisory boards.

‘Encouraging’ results lay groundwork for more trials in 2015

Oct. 28, 2014
| By Mary Engel

The first in a series of clinical trials designed to build on the promise of an HIV vaccine that showed modest protection when tested in Thailand has passed a key hurdle, according to a new study. It paves the way for larger HIV vaccine trials to move forward in South Africa.

Follow Us

Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.